AF
TNGX icon

Allworth Financial’s Tango Therapeutics TNGX Stock Holding History

Allworth Financial’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4K Buy
1,131
+568
+101% +$14K ﹤0.01% 2763
2026
Q1 		$11.8K Buy
563
+518
+1,151% +$7.21K ﹤0.01% 3393
2025
Q4 		$399 Buy
45
+7
+18% +$60 ﹤0.01% 4580
2025
Q3 		$320 Buy
38
+3
+9% +$20 ﹤0.01% 4534
2025
Q2 		$180 Buy
+35
New +$87 ﹤0.01% 4334
2025
Q1 		– Sell
-474
Closed -$1.46K – 4181
2024
Q4 		$1.46K Buy
+474
New +$2.2K ﹤0.01% 3271

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Allworth Financial's TNGX Position: Q2 2026 in Review

Allworth Financial increased its Tango Therapeutics (TNGX) stake by 101% in Q2 2026, buying an estimated $14K and bringing the position to 1,131 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2763.

Allworth Financial first reported a position in TNGX in Q4 2024 and has held it in 6 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Allworth Financial held 1,131 shares of Tango Therapeutics worth $35.4K as of Q2 2026.
  • Allworth Financial bought 568 Tango Therapeutics shares in Q2 2026, an estimated $14K.
  • Tango Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2763 holding.
  • Allworth Financial first reported a position in Tango Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.